Quality of Life and the Case for Antipsychotics


1.  Pies R: “How Antipsychotic Medication May Save Lives”

  1. Pies R: Long-term Antipsychotic Treatment: Effective and Often Necessary, with Caveats
  2. Berlim MT, Fleck MPA: Quality of life: presentation of the concept. Rev Bras Psiquiatr 2003;25(4):249-52
  3. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85.
  4. Heinrichs DW, Hanlon TE, Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388-98.
  5. Bobes J, Garcia-Portilla MP, Bascaran MT et al:Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9(2):215-26.
  6. Hamilton SH, Revicki DA, Genduso LA, Beasley CM. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial. Neuropsychopharmacology. 1998;18:41-49.
  7. Nasrallah HA, Duchesne I, Mehnert A et al: Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. J Clin Psychiatry. 2004;65:531-536.
  8. Beasley CM Jr, Sutton VK, Taylor CC et al: Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006 Feb;26(1):40-4.
  9. Vothknecht S, Schoevers RA, de Haan L. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review. Aust N Z J Psychiatry. 2011 Mar;45(3):182-92.
  10. Leucht S, Tardy M, Komossa K, et al: Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2012 May 16;(5):CD008016.
  11. Witte MM, Case MG, Schuh KJ, et al. Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia. Curr Med Res Opin. 2012 Mar;28(3):315-23. doi: 10.1185/03007995.2012.657300. Epub 2012 Jan 31.
  1. Isitt JJ, Nadipelli VR, Kouassi A et al: Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study. Schizophr Res. 2016 Jul;174(1-3):126-313
  2. Sohler N, Adams BG, Barnes DM, et al. Weighing the evidence for harm from long-term treatment with antipsychotic medications: a systematic review. Am J Orthopsychiatry. 2015 Dec 14.
  3. Memon MA: Brief Psychotic Disorder
  4. Frances A: Setting the Record Straight on Antipsychotics

For Further Reading:

Awad AG, Voruganti LN.The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia. CNS Drugs. 2013 Aug;27(8):625-36.

Staring AB, Mulder CL, Duivenvoorden HJ et al: Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life. Schizophr Res. 2009 Aug;113(1):27-33

Cortesi PA, Mencacci C, Luigi F, et al: Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. BMC Psychiatry. 2013 Mar 22;13:98.

Strakowski SM, Johnson JL, Delbello MP, et al:  HGDH Research Group. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res. 2005;78(2–3):161–169

Pies R: Trivializing the suffering of psychosis. Psychiatric Times. Dec. 22, 2014.


Quality of Life and the Case for Antipsychotics

This article originally appeared in:

Psychiatric Times

It is reprinted here with permission.


APA Reference
Pies,, R. (2019). Quality of Life and the Case for Antipsychotics. Psych Central. Retrieved on April 3, 2020, from


Scientifically Reviewed
Last updated: 21 Sep 2019
Last reviewed: By John M. Grohol, Psy.D. on 21 Sep 2019
Published on All rights reserved.